Author Index Volume 74 (2001)

Journal of Controlled Release 74 (2001) 381–384 www.elsevier.com / locate / jconrel

Author Index Volume 74 (2001)

Allen, T.M., see Pastorino, F. (74) 69 Anderson, C., see Omelyanenko, V.G. (74) 370 Anderson, D.M. and Cameransi, B.G., LyoCell TM technology applied to the solubilization and microencapsulation of antitumor compounds (74) 375 Antczak, C., Bauvois, B., Monneret, C. and Florent, J.-C., Targeting of acivicin prodrugs as antibody conjugates (74) 255 Anthony, F.H., see Bradley, M.O. (74) 233 Au, J.L.-S., Jang, S.H., Zheng, J., Chen, C.-T., Song, S., Hu, L. and Wientjes, M.G., Determinants of drug delivery and transport to solid tumors (74) 31

Donehower, R.C., Tumor targeting by conjugation of DHA to paclitaxel (74) 233 Brekken, R.A. and Thorpe, P.E., VEGF–VEGF receptor complexes as markers of tumor vascular endothelium (74) 173 Brem, H. and Gabikian, P., Biodegradable polymer implants to treat brain tumors (74) 63 Breur, G., see Turk, M.J. (74) 369 Budker, V.G., see Backer, M.V. (74) 349 Buhler, K.R., see Singer, J.W. (74) 243 Bungay, P.M., see Banerjee, R.K. (74) 193 Burke, T.G., see Bom, D. (74) 325

Backer, J.M., see Backer, M.V. (74) 349 Backer, J.M., see Gaidamakova, E.K. (74) 341 Backer, M.V., Budker, V.G. and Backer, J.M., Shiga-like toxinVEGF fusion proteins are selectively cytotoxic to endothelial cells overexpressing VEGFR-2 (74) 349 Backer, M.V., see Gaidamakova, E.K. (74) 341 Baker, S.D., see Bradley, M.O. (74) 233 Banerjee, R.K., van Osdol, W.W., Bungay, P.M., Sung, C. and Dedrick, R.L., Finite element model of antibody penetration in a prevascular tumor nodule embedded in normal tissue (74) 193 Bauvois, B., see Antczak, C. (74) 255 Belcourt, M.F., see King, I. (74) 371 Ben Meir, D., Satchi-Fainaro, R., Serroussi, E., Karby, S., Divinsky, I. and Lavi, S., Polymer-protein phosphatase 2C conjugate as a novel antitumour agent (74) 371 Benz, C.C., see Park, J.W. (74) 95 ´ Berenson, M., see Wroblewski, S. (74) 283 Bermudes, D., see King, I. (74) 371 Bermudes, D., see Tjuvajev, J. (74) 313 Bevins, R., see Bom, D. (74) 325 Bhatt, R., see Singer, J.W. (74) 243 Bingcang, A., see Bom, D. (74) 325 Blasberg, R., see Tjuvajev, J. (74) 313 Bom, D., Curran, D.P., Zhang, J., Zimmer, S.G., Bevins, R., Kruszewski, S., Howe, J.N., Bingcang, A., Latus, L.J. and Burke, T.G., The highly lipophilic DNA topoisomerase I inhibitor DB-67 displays elevated lactone levels in human blood and potent anticancer activity (74) 325 Bradley, M.O., Swindell, C.S., Anthony, F.H., Witman, P.A., Devanesan, P., Webb, N.L., Baker, S.D., Wolff, A.C. and

Cameransi, B.G., see Anderson, D.M. (74) 375 Catterall, L., see Rudge, S. (74) 335 Chakravarthy, A.B., see Hallahan, D.E. (74) 183 Chang, E.H., see Xu, L. (74) 115 Charnsangavej, C., see Ke, S. (74) 237 Chen, C.-T., see Au, J.L.-S. (74) 31 Cheng, C., see Woodle, M.C. (74) 309 Chilkoti, A., see Meyer, D.E. (74) 213 Clapp, D.W., see Reddy, J.A. (74) 77 Cleary, K., Freedman, M., Clifford, M., Lindisch, D., Onda, S. and Jiang, L., Image-guided robotic delivery system for precise placement of therapeutic agents (74) 363 Clemens, C.M., see Omelyanenko, V.G. (74) 370 Clifford, M., see Cleary, K. (74) 363 Cmelak, A.J., see Hallahan, D.E. (74) 183 Corrihons, F., see Schatzlein, A.G. (74) 357 Curran, D.P., see Bom, D. (74) 325

PII: S0168-3659( 01 )00422-9

¨ ¨ Dagar, S., Sekosan, M., Lee, B.S., Rubinstein, I. and Onyuksel, H., VIP receptors as molecular targets of breast cancer: implications for targeted imaging and drug delivery (74) 129 Davies, J.W., see Satchi-Fainaro, R. (74) 371 de Aos, I., see Varticovski, L. (74) 275 Dedrick, R.L., see Banerjee, R.K. (74) 193 Devanesan, P., see Bradley, M.O. (74) 233 de Vries, P., see Singer, J.W. (74) 243 Dewhirst, M.W., see Meyer, D.E. (74) 213 Divinsky, I., see Ben Meir, D. (74) 371 Donehower, R.C., see Bradley, M.O. (74) 233 Duncan, R., Gac-Breton, S., Keane, R., Musila, R., Sat, Y.N., Satchi, R. and Searle, F., Polymer–drug conjugates, PDEPT

382

Author Index Volume 74 (2001)

and PELT: basic principles for design and transfer from the laboratory to clinic (74) 135 Duncan, R., see Satchi-Fainaro, R. (74) 371 Ebert, C.D., see Omelyanenko, V.G. (74) 370 ˘´ ´ B. (74) 225 Etrych, T., see Rıhova, Fikes, J., see Riccobene, T. (74) 370 Florent, J.-C., see Antczak, C. (74) 255 Freedman, M., see Cleary, K. (74) 363 Fuchs, H., see Keller, J. (74) 259 Fukushima, S., see Nakanishi, T. (74) 295 Gabikian, P., see Brem, H. (74) 63 Gac-Breton, S., see Duncan, R. (74) 135 Gaidamakova, E.K., Backer, M.V. and Backer, J.M., Molecular vehicle for target-mediated delivery of therapeutics and diagnostics (74) 341 Ganesh, S., see Woodle, M.C. (74) 309 Gaur, U., see Mitra, S. (74) 317 Geng, L., see Hallahan, D.E. (74) 183 Ghosh, P.C., see Mitra, S. (74) 317 Gladysheva, I.P., Polekhina, O.V., Karmakova, T.A., Nemtsova, E.R., Yakubovskaya, R.I., Shen, W.-C., Kennedy, A.R. and Larionova, N.I., Potential of block copolymer- and immunoconjugates for tumor-targeted delivery of Bowman–Birk soybean proteinase inhibitor (74) 303 Gonzalez, A., see Hallahan, D.E. (74) 183 Goodwin, S., see Leakakos, T. (74) 372 Greenwald, R.B., PEG drugs: an overview (74) 159 Gu, C., see Woodle, M.C. (74) 309 Hailu, H., see Satchi-Fainaro, R. (74) 371 Hallahan, D.E., Geng, L., Cmelak, A.J., Chakravarthy, A.B., Martin, W., Scarfone, C. and Gonzalez, A., Targeting drug delivery to radiation-induced neoantigens in tumor microvasculature (74) 183 Halpern, P., see Riccobene, T. (74) 370 Heasley, E., see Singer, J.W. (74) 243 Heisler, I., see Keller, J. (74) 259 Hill, J., see Leakakos, T. (74) 372 Hong, K., see Park, J.W. (74) 95 ˘´ ´ B. (74) 225 Hovorka, O., see Rıhova, Howe, J.N., see Bom, D. (74) 325 Hrushesky, W.J.M., Tumor chronobiology (74) 27 Hu, L., see Au, J.L.-S. (74) 31 Iakoubov, L.Z., see Torchilin, V.P. (74) 373 Ittensohn, M., see King, I. (74) 371 Jain, R.K., Delivery of molecular medicine to solid tumors: lessons from in vivo imaging of gene expression and function (74) 7 Jang, S.H., see Au, J.L.-S. (74) 31 ˘´ ´ ´ M., see Rıhova, ´ B. (74) 225 Jelınkova, Jiang, L., see Cleary, K. (74) 363 Karby, S., see Ben Meir, D. (74) 371

Karmakova, T.A., see Gladysheva, I.P. (74) 303 ˇ ´ P., Minko, T., Tabibi, S.E. and Kasuya, Y., Lu, Z.-R., Kopeckova, ˇ Kopecek, J., Synthesis and characterization of HPMA copolymer–aminopropylgeldanamycin conjugates (74) 203 Kataoka, K., see Nakanishi, T. (74) 295 Kataoka, K., see Nishiyama, N. (74) 83 Ke, S., Milas, L., Charnsangavej, C., Wallace, S. and Li, C., Potentiation of radioresponse by polymer–drug conjugates (74) 237 Keane, R., see Duncan, R. (74) 135 Keller, J., Heisler, I., Tauber, R. and Fuchs, H., Development of a novel molecular adapter for the optimization of immunotoxins (74) 259 Kennedy, A.R., see Gladysheva, I.P. (74) 303 King, I., Lin, S., Le, T.X., Pianta, T.J., Belcourt, M.F., Luo, X., Li, Z., Bermudes, D., Ittensohn, M. and Zheng, L.M., Tumorselective delivery of cytosine deaminase by Salmonella typhimurium in murine tumor models (74) 371 King, I., see Tjuvajev, J. (74) 313 Kirpotin, D.B., see Park, J.W. (74) 95 Klein, P., see Singer, J.W. (74) 243 Koda, J., see Rudge, S. (74) 335 Kong, G.A., see Meyer, D.E. (74) 213 Konno, T., see Maeda, H. (74) 47 Kioecek, J., see Tabibi, S.E. (74) 1 ˇ Kopecek, J., see Kasuya, Y. (74) 203 ˇ ˇ ´ P., Minko, T., Lu, Z.-R. and Peterson, Kopecek, J., Kopeckova, C.M., Water soluble polymers in tumor targeted delivery (74) 147 ˇ Kopecek, J., see Lu, Z.-R. (74) 263 ˇ Kopecek, J., see Minko, T. (74) 370 ˇ Kopecek, J., see Shiah, J.-G. (74) 249 ˇ Kopecek, J., see Tijerina, M. (74) 269 ˇ Kopecek, J., see Varticovski, L. (74) 275 ˇ ´ Kopecek, J., see Wroblewski, S. (74) 283 ˇ ´ P., see Kasuya, Y. (74) 203 Kopeckova, ˇ ´ P., see Kopecek, ˇ Kopeckova, J. (74) 147 ˇ ´ P., see Lu, Z.-R. (74) 263 Kopeckova, ˇ ´ P., see Minko, T. (74) 370 Kopeckova, ˇ ´ P., see Shiah, J.-G. (74) 249 Kopeckova, ˇ ´ P., see Tijerina, M. (74) 269 Kopeckova, ˇ ´ P., see Wroblewski, ´ Kopeckova, S. (74) 283 ˘´ ´ˇ M., see Rıhova, ´ B. (74) 225 Kovar, Kruszewski, S., see Bom, D. (74) 325 Larionova, N.I., see Gladysheva, I.P. (74) 303 Latus, L.J., see Bom, D. (74) 325 Lavi, S., see Ben Meir, D. (74) 371 Le, T.X., see King, I. (74) 371 Leakakos, T., Hill, J., Peterson, C. and Goodwin, S., Pulmonary delivery of doxorubicin through the bronchial artery in a swine model using magnetically targeted carriers (74) 372 Lee, B.S., see Dagar, S. (74) 129 Li, C., see Ke, S. (74) 237 Li, Z., see King, I. (74) 371 Lin, S., see King, I. (74) 371 Lincon, C., see Riccobene, T. (74) 370 Lindisch, D., see Cleary, K. (74) 363

Author Index Volume 74 (2001) Low, P.S., see Reddy, J.A. (74) 77 Low, P.S., see Turk, M.J. (74) 369 Lu, Z.-R., see Kasuya, Y. (74) 203 ˇ Lu, Z.-R., see Kopecek, J. (74) 147 ˇ ´ P. and Kopecek, ˇ Lu, Z.-R., Shiah, J.-G., Kopeckova, J., Preparation and biological evaluation of polymerizable antibody Fab9 fragment targeted polymeric drug delivery system (74) 263 Lu, Z.-R., see Varticovski, L. (74) 275 Lukyanov, A.L., see Torchilin, V.P. (74) 373 Luo, X., see King, I. (74) 371 Luo, X., see Tjuvajev, J. (74) 313 Maeda, H., Sawa, T. and Konno, T., Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS (74) 47 Maitra, A.N., see Mitra, S. (74) 317 Marks, J.D., see Park, J.W. (74) 95 Martin, W., see Hallahan, D.E. (74) 183 Matsumura, Y., see Nakanishi, T. (74) 295 Meyer, D.E., Shin, B.C., Kong, G.A., Dewhirst, M.W. and Chilkoti, A., Drug targeting using thermally responsive polymers and local hyperthermia (74) 213 Miceli, R., see Riccobene, T. (74) 370 Milas, L., see Ke, S. (74) 237 Minko, T., see Kasuya, Y. (74) 203 ˇ Minko, T., see Kopecek, J. (74) 147 ˇ ´ P. and Kopecek, ˇ Minko, T., Kopeckova, J., Antitumor activity and apoptosis signaling pathways of HPMA copolymer-bound doxorubicin (74) 370 Mitchell, K., see Varticovski, L. (74) 275 Mitra, S., Gaur, U., Ghosh, P.C. and Maitra, A.N., Tumour targeted delivery of encapsulated dextran–doxorubicin conjugate using chitosan nanoparticles as carrier (74) 317 Mongayt, D.A., see Torchilin, V.P. (74) 373 Monneret, C., see Antczak, C. (74) 255 Moore, B.D., see Schatzlein, A.G. (74) 357 Musila, R., see Duncan, R. (74) 135 Nakanishi, T., Fukushima, S., Okamoto, K., Suzuki, M., Matsumura, Y., Yokoyama, M., Okano, T., Sakurai, Y. and Kataoka, K., Development of the polymer micelle carrier system for doxorubicin (74) 295 Nemtsova, E.R., see Gladysheva, I.P. (74) 303 Nielsen, U.B., see Park, J.W. (74) 95 Nishiyama, N. and Kataoka, K., Preparation and characterization of size-controlled polymeric micelle containing cis-dichlorodiammineplatinum(II) in the core (74) 83 Okamoto, K., see Nakanishi, T. (74) 295 Okano, T., see Nakanishi, T. (74) 295 Omelyanenko, V.G., Anderson, C., Clemens, C.M., Prakash, R.K., Sanders, S.W. and Ebert, C.D., Effect of drug loading on interactions of polyethylene glycol monomethyl ether–doxorubicin conjugates with cancer cells (74) 370 Onda, S., see Cleary, K. (74) 363 ¨ ¨ Onyuksel, H., see Dagar, S. (74) 129

383

Pan, Y., see Woodle, M.C. (74) 309 Papahadjopoulos, D., see Park, J.W. (74) 95 Park, J.W., Kirpotin, D.B., Hong, K., Shalaby, R., Shao, Y., Nielsen, U.B., Marks, J.D., Papahadjopoulos, D. and Benz, C.C., Tumor targeting using anti-her2 immunoliposomes (74) 95 Pastorino, F., Stuart, D., Ponzoni, M. and Allen, T.M., Targeted delivery of antisense oligonucleotides in cancer (74) 69 ˘´ ´ B. (74) 225 Pechar, M., see Rıhova, Peterson, C., see Leakakos, T. (74) 372 Peterson, C., see Rudge, S. (74) 335 ˇ Peterson, C.M., see Kopecek, J. (74) 147 Peterson, C.M., see Shiah, J.-G. (74) 249 Pianta, T.J., see King, I. (74) 371 Pirollo, K.F., see Xu, L. (74) 115 Polekhina, O.V., see Gladysheva, I.P. (74) 303 Ponzoni, M., see Pastorino, F. (74) 69 Prakash, R.K., see Omelyanenko, V.G. (74) 370 Rammohan, R., see Torchilin, V.P. (74) 373 Reddy, J.A., Clapp, D.W. and Low, P.S., Retargeting of viral vectors to the folate receptor endocytic pathway (74) 77 Riccobene, T., Miceli, R., Lincon, C., Halpern, P., Fikes, J. and Sung, C., Rapid and specific targeting of radiolabeled BLyS to lymphoid tissues (74) 370 ˘´ ˇ ´ B., Etrych, T., Pechar, M., Jelınkova, ´ ´ M., Stastny, ´ M., Rıhova, ´ˇ M. and Ulbrich, K., Doxorubicin bound Hovorka, O., Kovar, to a HPMA copolymer carrier through hydrazone bond is effective also in a cancer cell line with a limited content of lysosomes (74) 225 Rubinstein, I., see Dagar, S. (74) 129 Rudge, S., Peterson, C., Vessely, C., Koda, J., Stevens, S. and Catterall, L., Adsorption and desorption of chemotherapeutic drugs from a magnetically targeted carrier (MTC) (74) 335 Rutherford, C., see Schatzlein, A.G. (74) 357 Sakurai, Y., see Nakanishi, T. (74) 295 Samokhin, G.P., see Torchilin, V.P. (74) 373 Sanders, S.W., see Omelyanenko, V.G. (74) 370 Sat, Y.N., see Duncan, R. (74) 135 Satchi, R., see Duncan, R. (74) 135 Satchi-Fainaro, R., see Ben Meir, D. (74) 371 Satchi-Fainaro, R., Hailu, H., Davies, J.W., Summerford, C. and Duncan, R., Synthesis, in vitro and in vivo characterisation of HPMA-C-Dox and HPMA-b-L as a novel PDEPT combination (74) 371 Sausville, E.A., Scientific summation and future goals (74) 1 Sawa, T., see Maeda, H. (74) 47 Scarfone, C., see Hallahan, D.E. (74) 183 Scaria, P., see Woodle, M.C. (74) 309 Schatzlein, A.G., Rutherford, C., Corrihons, F. and Moore, B.D., Phage derived peptides for targeting of doxorubicin conjugates to solid tumours (74) 357 Searle, F., see Duncan, R. (74) 135 Sekosan, M., see Dagar, S. (74) 129 Serroussi, E., see Ben Meir, D. (74) 371 Shabani, M., Simmon, M. and Smith, D.J., Transdermal delivery

384

Author Index Volume 74 (2001)

of nitric oxide (NO) from NO complexes (NONOates) (74) 376 Shalaby, R., see Park, J.W. (74) 95 Shao, Y., see Park, J.W. (74) 95 Shen, W.-C., see Gladysheva, I.P. (74) 303 Shiah, J.-G., see Lu, Z.-R. (74) 263 ˇ ´ P., Peterson, C.M., Straight, Shiah, J.-G., Sun, Y., Kopeckova, ˇ R.C. and Kopecek, J., Combination chemotherapy and photodynamic therapy of targetable N-(2-hydroxypropyl)methacrylamide copolymer–doxorubicin / mesochlorin e 6 -OV-TL 16 antibody immunoconjugates (74) 249 Shin, B.C., see Meyer, D.E. (74) 213 Simmon, M., see Shabani, M. (74) 376 Singer, J.W., Bhatt, R., Tulinsky, J., Buhler, K.R., Heasley, E., Klein, P. and de Vries, P., Water-soluble poly-( L-glutamic acid)–Gly-camptothecin conjugates enhance camptothecin stability and efficacy in vivo (74) 243 Smith, D.J., see Shabani, M. (74) 376 Song, S., see Au, J.L.-S. (74) 31 ˇ ˘´ ´ M., see Rıhova, ´ B. (74) 225 Stastny, Stevens, S., see Rudge, S. (74) 335 Straight, R.C., see Shiah, J.-G. (74) 249 Stuart, D., see Pastorino, F. (74) 69 Subramanian, K., see Woodle, M.C. (74) 309 Summerford, C., see Satchi-Fainaro, R. (74) 371 Sun, Y., see Shiah, J.-G. (74) 249 Sung, C., see Banerjee, R.K. (74) 193 Sung, C., see Riccobene, T. (74) 370 Suzuki, M., see Nakanishi, T. (74) 295 Swindell, C.S., see Bradley, M.O. (74) 233 ˇ Tabibi, S.E., Kopecek, J., Preface (74) xi Tabibi, S.E., see Kasuya, Y. (74) 203 Tauber, R., see Keller, J. (74) 259 Thorpe, P.E., see Brekken, R.A. (74) 173 ˇ ´ P. and Kopecek, ˇ Tijerina, M., Kopeckova, J., The effects of subcellular localization of N-(2-hydroxypropyl) methacrylamide copolymer-Mce 6 conjugates in a human ovarian carcinoma (74) 269 Titmas, R., see Woodle, M.C. (74) 309 Tjuvajev, J., Blasberg, R., Luo, X., Zheng, L.M., King, I. and Bermudes, D., Salmonella-based tumor-targeted cancer therapy: tumor amplified protein expression therapy (TAPET TM ) for diagnostic imaging (74) 313 Torkelson, S., see Woodle, M.C. (74) 309 Torchilin, V.P., Iakoubov, L.Z., Samokhin, G.P., Rammohan, R., Mongayt, D.A. and Lukyanov, A.L., Tumor cell surface-bound

nucleosomes: universal molecular targets for tumoricidal autoantibodies (74) 373 Tulinsky, J., see Singer, J.W. (74) 243 Turk, M.J., Waters, D.J., Breur, G., Widmer, W.R. and Low, P.S., Folate-mediated targeting of liposomes to tumor cells and Mac-1 expressing cells in-vivo (74) 369 ˘´ ´ B. (74) 225 Ulbrich, K., see Rıhova, van Osdol, W.W., see Banerjee, R.K. (74) 193 ˇ Varticovski, L., Lu, Z.-R., Mitchell, K., De Aos, I. and Kopecek, J., Water-soluble HPMA copolymer–wortmannin conjugate retains phosphoinositide 3-kinase inhibitory activity in vitro and in vivo (74) 275 Vessely, C., see Rudge, S. (74) 335 Wallace, S., see Ke, S. (74) 237 Waters, D.J., see Turk, M.J. (74) 369 Webb, N.L., see Bradley, M.O. (74) 233 Weng, K., see Woodle, M.C. (74) 309 Widmer, W.R., see Turk, M.J. (74) 369 Wientjes, M.G., see Au, J.L.-S. (74) 31 Witman, P.A., see Bradley, M.O. (74) 233 Wolff, A.C., see Bradley, M.O. (74) 233 Woodle, M.C., Scaria, P., Ganesh, S., Subramanian, K., Titmas, R., Cheng, C., Yang, J., Pan, Y., Weng, K., Gu, C. and Torkelson, S., Sterically stabilized polyplex: ligand-mediated activity (74) 309 ´ ˇ ´ P. and Kopecek, ˇ Wroblewski, S., Berenson, M., Kopeckova, J., Potential of lectin-N-(2-hydroxypropyl)methacrylamide copolymer-drug conjugates for the treatment of pre-cancerous conditions (74) 283 Xu, L., Pirollo, K.F. and Chang, E.H., Tumor-targeted p53-gene therapy enhances the efficacy of conventional chemo / radiotherapy (74) 115 Yakubovskaya, R.I., see Gladysheva, I.P. (74) 303 Yang, J., see Woodle, M.C. (74) 309 Yokoyama, M., see Nakanishi, T. (74) 295 Zhang, J., see Bom, D. (74) 325 Zheng, J., see Au, J.L.-S. (74) 31 Zheng, L.M., see King, I. (74) 371 Zheng, L.M., see Tjuvajev, J. (74) 313 Zimmer, S.G., see Bom, D. (74) 325